Literature DB >> 18552347

Interlaminar approach for epiduroscopy in patients with failed back surgery syndrome.

M Avellanal1, G Diaz-Reganon.   

Abstract

BACKGROUND: Epiduroscopy is a relatively new diagnostic and therapeutic technique used in patients with chronic low back pain with or without radiculopathy. We present our experience with a new interlaminar approach in patients with failed back surgery syndrome (FBSS).
METHODS: Patients with severe symptoms of FBSS who did not respond to other treatments were included. Lumbar epiduroscopy was performed via interlaminar approach through a 14 G epidural needle under fluoroscopy. A flexible, 0.77 mm, endoscope was introduced through a 4F catheter into the epidural space and advanced in a cephalad direction. Flushes of normal saline through the catheter (via a Y-adapter/haemostasis valve) enabled distension of the space. Adhesions were mechanically mobilized under direct vision. A mixture of triamcinolone 60 mg, hyaluronidase 600 IU, and bupivacaine 0.0625% was instilled.
RESULTS: Nineteen patients were included. The mean number of operations at lumbar level was 2.26. Major findings included adhesions, inflammation, stenosis, and nerve root hypotrophia. The visual analogue scale (VAS) score was 7.89 at baseline, 5.95 (P<0.001) 3 months later, and 6.05 (P<0.001) 6 months later. Six patients (31.6%) did not show any improvement, and six other patients showed a very significant improvement (at least three points reduction in the VAS) 3 months later. We had four cases of dural puncture, but only one patient required hospital admission.
CONCLUSIONS: We have described a new procedure for epiduroscopy with approximately 50% reduced outer diameter of the catheter, which allows interlaminar approach. Its diagnostic efficacy is clear and there were a significant number of patients who had improved outcome.

Entities:  

Mesh:

Year:  2008        PMID: 18552347     DOI: 10.1093/bja/aen165

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  9 in total

1.  Delayed allergic reaction to secondary administrated epidural hyaluronidase.

Authors:  A Reum Park; Woong Mo Kim; Bong Ha Heo
Journal:  Korean J Pain       Date:  2015-04-01

2.  Acute urticaria caused by the injection of goat-derived hyaluronidase.

Authors:  Joo-Hee Kim; Gil-Soon Choi; Young-Min Ye; Dong-Ho Nahm; Hae-Sim Park
Journal:  Allergy Asthma Immunol Res       Date:  2009-09-25       Impact factor: 5.764

Review 3.  Neuropathic Pain after Spinal Surgery.

Authors:  Jae Hwan Cho; Jae Hyup Lee; Kwang-Sup Song; Jae-Young Hong
Journal:  Asian Spine J       Date:  2017-08-07

4.  Complication of epiduroscopy: a brief review and case report.

Authors:  Maurizio Marchesini; Edoardo Flaviano; Valentina Bellini; Marco Baciarello; Elena Giovanna Bignami
Journal:  Korean J Pain       Date:  2018-10-01

5.  Evaluation of the Efficacy of Epiduroscopic Laser Neural Discectomy in Lumbar Disc Herniations: Retrospective Analysis of 163 Cases- Evaluation of the Efficacy of ELNP.

Authors:  Ali Metin Ülgen; Serbülent Gökhan Beyaz; Mustafa Erkan Inanmaz; Fatih Şahin
Journal:  Pain Res Manag       Date:  2020-10-29       Impact factor: 3.037

6.  Efficacy of Minimally Invasive Trans-Sacral Canal Plasty between Patients with and without Failed Back Surgery Syndrome.

Authors:  Haruki Funao; Kimiaki Yokosuka; Junichi Ukai; Kazuo Nakanishi; Masaaki Paku; Takashi Tomita; Masahiro Hoshino; Takanori Saito; Ken Ishii; Koji Sato
Journal:  Medicina (Kaunas)       Date:  2022-02-07       Impact factor: 2.430

7.  Iatrogenic intradural lumbosacral cyst following epiduroscopy.

Authors:  Kyeong-Sik Ryu; Nitesh Kumar Rathi; Geol Kim; Chun-Kun Park
Journal:  J Korean Neurosurg Soc       Date:  2012-11-30

Review 8.  Epidural lysis of adhesions.

Authors:  Frank Lee; David E Jamison; Robert W Hurley; Steven P Cohen
Journal:  Korean J Pain       Date:  2013-12-31

9.  One-year results of an algorithmic approach to managing failed back surgery syndrome.

Authors:  Martin Avellanal; Gonzalo Diaz-Reganon; Alejandro Orts; Silvia Soto
Journal:  Pain Res Manag       Date:  2014-09-15       Impact factor: 3.037

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.